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 Flagellin is the principal structural protein in the locomotive organ flagellum present 
on flagellated bacteria, and is known to be an important evolutionarily conserved PAMP. 
Flagellin has been shown to bind to the PRR TLR5 which induces innate immune system 
responses and signaling pathways. In mammals, much focus has been placed on this protein in 
vaccine studies for its possible function as an adjuvant. In paper I, flagellin (FlaD from Vibrio 
anguillarum) was recombinantly produced in two forms, full-length (FDL) and a truncated 
form (FDS) with portions of the N- and C-termini removed to prevent polymerization. Both 
forms of flagellin were tested alone and in combination with an antigen in a dose response 
study to determine the most effective dosage to produce a strong immune response. A 
polyclonal antibody for FDS was produced and showed good specificity in immunoblot 
testing. Cell culture was used to compare the NF- B response after stimulation with FDL 
versus FDS and resulted in a significantly larger response in cells stimulated with FDL. 
QPCR mRNA gene expression results showed a strong innate immune response with a 
number of genes known to be induced downstream by the TLR signaling pathway up-
regulated including important TLR5S and inflammatory cytokines and chemokines (TNF , 
IL-6, IL-8, IL-1 ). Due to lower production and decreased stability of FDL, FDS was selected 
for further injection studies in salmon.  
 In paper II, microarray analysis further explored the salmon’s response to injection of 
flagellin with and without the model antigen ovalbumin. Injection with flagellin with and 
without ovalbumin caused reproducible gene up-regulation of inflammatory cytokines, 
chemokines and receptors (IL-8, TNFRSF11B, IL-1R), antimicrobial peptides (hepcidin, 
cathelicidin), immune genes (C/EBP, thioredoxin, C-type lectin receptor B), complement 
genes (complement component C7 and C7-1), peptidases (MMP-9) and genes involved in the 
Ras/MAPK pathway (Ras-related proteins). Down-regulation of interesting immune genes 
also occurred including myxovirus resistance 1, clusterin-1 and LPS-induced TNF-
homolog. Some genes exhibited early, delayed or extended response over the sampling time 
and flagellin seemed to be the key component to eliciting a response.  A selection of up-
regulated genes from the microarray studies were validated by QPCR. Flagellin was shown to 
induce the innate immune response in Atlantic salmon with further studies needed to 






Abbreviation Full name  Abbreviation Full name 
AMP antimicrobial 
peptide 
 IRF4                          interferon-
regulatory factor 4  
APC antigen presenting 
cell 
 JNK c-Jun N-terminal 
kinase 
ATF-2                       activating 
transcription factor 
2 
 LRR leucine-rich repeat 
CARD caspase activation 
recruitment domain 
 LPH hemocyanin from 
Limulus polyhemus 
hemolymph 
CD cluster of 
differentiation  
 LPS lipopolysaccharide 
cDNA Complementary 
DNA 
 MAF macrophage 
activating factor 
CD4+ or TH cells       helper T cell  MAPK mitogen-activated 
protein kinase 
CD8+ or CTL            cytotoxic T cell  MD-2                         lymphocyte antigen 
96 
cGRASP consortium for 
Genomic Research 
on All Salmoninds 
 MHC major 
histocompatibility 
complex 
D domains  MMP9 matrix 
metalloproteinase-9 
DC dendritic cell  mRNA Messenger 
ribonucleic acid 




dsRNA   double-stranded  
ribonucleic acid 
 Naip5 neuronal apoptosis 




 NLRC4 NLR family CARD 
domain-containing 
protein 4 





 NF-kB                        nuclear factor 
kappa-light-chain-
enhancer of 
activated B cell 
FCA Freund’s complete 
adjuvant 
 IHNV infectious 
hematopoietic 
necrosis virus 
FDL FlaD full-length  IPNV infectious 
pancreatic necrosis 
virus 
FDS FlaD truncated  ISA                            infectious salmon 
anemia   





 IRAK    interleukin-1 
receptor-associated 
kinase 
Hsp heat shock protein  IL interleukin 
I B NF- B inhibitor  IKK inhibitor of NF- B 
kinase complex 
IFN interferon  Ig immunoglobulin 




     
Abbreviation Full name    
NITR novel immune-type 
receptor 





   




   
OVA ovalbumin    
PAMP pathogen associated 
molecular pattern 
   
PRK protein kinase 
RNA-activated    
   
PLG poly-lactide-co-
glycolide 
   
PRR pattern recognition 
receptors 
   
RLA relative luciferase 
assay 
   
RPS relative percent 
survival 
   
QPCR quantitative real 
time polymerase 
chain reaction 
   
ssRNA single-stranded 
ribonucleic acid 
   
TAB2 TGF-  activated 
kinase 1/MAP3K7 
binding protein 2       
   
TAK1 TGF-  activated 
kinase 1 
   
TCR T cell receptor    
TFH follicular B Helper 
T cells 
   
TGF-                         transforming 
growth factor-beta  
   
TH2 T helper 2 cells    
TIR Toll/IL-1 receptor     
TLR Toll-like receptor    
TLR5S Toll-like receptor 5 
soluble 
   
TLR5M Toll-like receptor 5 
membrane-bound 
   
 Tumor necrosis 
factor-  
   
TNFSF11B 
super family 11B 
   
TRAF6 TNF receptor 
associated factor 6 
   
Treg regulatory T cell    
VHN viral hemorrhagic 
septicemia 






Norway has become one of the largest producers of Atlantic salmon worldwide but it 
has not been without overcoming numerous disease challenges throughout its development. 
Many of the bacterial diseases have been effectively reduced through the use of vaccines but 
viral diseases remain a problem for growers. There may be a need for more efficient vaccine 
components (adjuvants and antigens) that are able to combat the problem of viral and 
intracellular bacterial diseases in salmon aquaculture [1]. With recent advances in fish 
immunology, there are new and exciting areas of the immune system to target including Toll-
like receptor (TLR) ligands. Mammalian research has provided evidence of improved survival 
and antibody production with the use of flagellin, a TLR5 ligand. Fish live in an aqueous 
environment surrounded by numerous pathogens therefore a strong first line of defense is 
imperative to their survival. By focusing on flagellin, a key structural protein in the bacterial 
flagella, it was possible to elucidate the role that flagellin plays in stimulating the innate 
immune system in salmon. This not only advances the knowledge of salmonid immunology 
but also can assist in the formulation of more successful vaccine adjuvants.  
1.1 The immune system 
1.1.1 The innate immune system in mammals 
The innate immune system is the first line of host defense against invading pathogens 
and has been found in all classes of animal life, from plants to mammals [2]. This type of 
defense strategy occurs almost immediately (within minutes up to a few days) and includes 
physical barriers, antimicrobial peptides, natural killer cells, receptors, etc. In this thesis focus 
has been placed on the innate immune receptors due to their role in the response to flagellin. 
The innate immune response relies on non-self discrimination which is the recognition of 
specific microbial components (lipopolysaccharide (LPS), flagellin, lipoglycans, etc) that are 
not found in host cells. This prevents the immune system from reacting to its own cells. These 
microbial components are called pathogen associated molecular patterns (PAMPs) and are 
often essential for the microbes survival which prevents them from being mutated over the 
course of evolution. Pathogen associated molecular patterns bind to pattern recognition 
receptors (PRRs) which are unable to undergo somatic recombination but have developed a 
protective adaptation to potentially harmful microbes [3, 4]. The inability to undergo somatic 
recombination means that these receptors are encoded in the germ-line and do not require 




receptors on all cells of the same lineage. The innate immune system does not respond faster 
or more powerfully to pathogens, even upon repeat exposure, meaning that there is no 
immunological memory. 
There are numerous types of innate immune receptors in mammals. They are grouped 
into three main categories; secreted PRRs (mannan-binding lectin, C-reactive protein, serum 
amyloid protein), cell-surface receptors (macrophage mannose receptor, macrophage 
scavenger receptor) and intracellular PRRs (protein kinase RNA-activated (PRK), nucleotide-
binding oligomerization domain (NOD)-like receptors) [4]. Toll-like receptors are a very 
well-known and important group of receptors in the innate immune response. Ten TLRs had 
been discovered in humans and mice [4, 5] but recently a novel TLR has been discovered [6]. 
TLR13 responds specifically to vesicular stomatitis virus in mouse cells lines but not to other 
known TLR ligands and appears to be an intracellular TLR. TLRs vary from each other in 
ligand specificities, expression patterns and the target genes that they can induce. Some are 
expressed on the cell-surface of important immune cells while other are expressed on the 
endosomal surface [4]. Due to the focal point of this work being on the role of flagellin in the 
innate immune response, much of the focus on receptors will be placed on TLR5 due to its 
established role as a flagellin receptor.   
Table 1. Innate and adaptive immunity. Adapted from Janeway and Medzhitov, 2002 [4]. 
Property Innate immune system Adaptive immune system 
Receptors Fixed in genome 
Rearrangement is not necessary 





All cells of a class identical 
Clonal 
All cells of a class distinct 
Recognition Conserved molecular patterns 
(LPS, glycans, flagellin) 
Details of molecular structure 
(proteins, peptides, carbohydrates) 
Non-self  
discrimination 
Perfect: selected over evolutionary 
time 
Imperfect: selected in individual 
somatic cells 
Action time Immediate activation of effectors Delayed activation or anergy 
Response Co-stimulatory molecules 
Cytokines (IL- -6) 
Chemokines (IL-8) 
Clonal expansion or anergy 
IL-2 
Effector cytokines: (IL-4,  
  
1.1.2 The adaptive immune system in mammals 
 When the innate immune system is unable to free the host of a pathogen challenge, the 
adaptive immune system is activated. This activation takes longer to mount than the innate 
immune response (days to weeks), but is more specific. The innate immune system is able to 




stimulatory molecules (cluster of differentiation (CD) 80, CD83) on antigen presenting cells 
(APCs) [4]. The adaptive immune system can also activate the innate immune response to aid 
in the elimination of pathogens. It has clonally distributed receptors that must undergo 
rearrangement of the gene segments to allow for the recognition of particular features of 
pathogens. This permits the host to recognize a wide variety of microbes. Immunological 
memory is elicited after repeat exposure to a microbe thereby mounting stronger, faster and 
more specific responses after re-encountering the same microbe [3, 4, 7, 8].  
 There are two key cell types involved in the adaptive immune response, B and T 
lymphocytes. B cells function in the production of antibodies which can recognize a wide 
variety of native macromolecules (proteins, polysaccharides, lipids and nucleic acids) and this 
is known as humoral immunity. After recognition of a specific antigen, the B cell receives 
signals from T helper 2 (TH2) cells which allow them to produce effector cells, called plasma 
cells which secrete antibodies (immunoglobulins, Ig). In mammals there are five types of 
antibodies; IgA, IgD, IgE, IgG and IgM, each with different biological properties and 
handling different kinds of antigens [3]. In comparison, T cells only distinguish peptide 
fragments of protein antigens and only when they are presented on major histocompatibility 
complex (MHC) molecules of the host cell.  Cytotoxic T cells (CD8+ or CTL cells) recognize 
peptides presented on MHC-I which are present on all nucleated cells whereas helper T cells 
(CD4+ or TH cells) recognize peptides on MHC-II which are found on APCs (macrophages, B 
cells and dendritic cells). There are two main types of T helper cells; TH1 cells which are 
involved in the elimination or suppression of intracellular pathogens and TH2 cells which 
eliminate or neutralize extracellular bacteria, parasites and toxins and activate B cells. 
Regulatory T cells (Treg) limit and suppress the immune system and may play a role in 
controlling abnormal immune responses to self-antigens. Furthermore, TH17 cells are known 
to be involved in various autoimmune diseases and function in anti-microbial immunity at 
epithelial/mucosal barriers [3]. TH9 and TH21 are newly discovered T cell subsets that emerge 
after viral infection but little is known about their functional roles [9]. TH9 cells which were 
shown to reprogram TH2 cells towards TH9 under the influence of transforming growth factor-
beta (TGF- ), produce interleukin-9 (IL-9) [10, 11] and require interferon-regulatory factor 4 
(IRF4) for its development [12]. The T follicular helper (TFH) cells are a subset of CD4+ T 
cells which play a key role in supporting protective antibody responses derived from antigen-




1.1.3 The innate immune system in fish 
Fish are important in the study of the immune system because they are the earliest 
known class of vertebrates to possess both innate and adaptive immunity. The adaptive 
immune system of fish is not as highly developed as in mammals therefore fish strongly rely 
on the innate system for protection [14].  
 Antimicrobial peptides (AMPs) are small molecules with a broad spectrum of potent 
immune activities against bacteria, fungi, parasites and viruses [15]. Their functions include 
microbicidal effects, recruitment of neutrophils and fibroblasts, promotion of mast cells 
degranulation, enhancement of phagocytosis and decreasing fibrinolysis, as well as the 
prevention of tissue injury by decreasing cytokine production and stimulating apoptosis of 
activated/infected cells [5, 15, 16]. While a number of AMPs have been discovered in fish 
(hepcidin [17, 18], cathelicidins [19, 20] and lysozymes [21, 22]) there still appears to be less 
diversity in comparison to other classes of vertebrates [5]. This is also true for other important 
components of the fish innate immune system, including chemokines. In contrast, the 
complement system of fish appears to contain a number of isoforms and polymorphisms of 
some of the important complement components that are structurally and functionally diverse 
[5, 23]. The diversity in the fish complement system could prove to be important in an 
evolutionary perspective with fish expanding their recognition capabilities of the innate 
immune system [24]. A number of cytokines that are known in mammals have also been 
found in fish and have been shown to have similar functions as in mammals (Tumor necrosis 
factor  (TNF ), IL- interferon’s (IFNs)) [5, 24].  
 There are some differences between mammalian and fish receptors of the innate 
immune system. Fish possess some novel receptors that have not been found in mammals but 
behave in a similar manner functionally [5, 25]. Two of these receptors are non-specific 
cytotoxic cell receptors (NCCR) which behave similarly to natural killer (NK) cells of 
mammals and novel immune-type receptors (NITR) which are members of the Ig superfamily 
and have no known Ig homolog in mammals. A soluble immune-type receptor (SITR) has 
been found in carp and resembles CD300 found in mammalian species [26]. Carp SITR has 
been shown to be expressed abundantly in macrophages and be secreted upon stimulation 
with the protozoan parasite Trypanoplasma borreli [27]. Currently there are more than 17 
different TLRs identified in numerous fish species and they share many functional properties 
with their mammalian equivalents [28]. Fish possess many of the same TLRs as mammals 




1.1.4 The adaptive immune system in fish 
 The initial emergence of both the innate and adaptive immune systems occurred in fish. 
There are a number of similarities between the mammalian and fish adaptive immune systems 
with most of the fundamental features present in fish. Some of the key similarities and 
differences will be highlighted here. One important difference is the immunological organs in 
fish which lack bone marrow, lymph nodes and Peyer’s patches [29, 30]. Their 
immunological organs are the thymus, anterior (head) kidney, spleen and mucosa-associated 
lymphoid tissue.  
A recent review of CTLs in teleost fish suggests the presence of CD8+ CTLs in fish 
similar to higher vertebrates (Nakanishi et al., in press [31]). This was based on previous 
messenger ribonucleic acid (mRNA) expression studies of T cell surface marker genes in 
alloantigen- or virus-specific effe
in ginbuna (Carassius auratus langsdorfi
catfish (Nakanishi et al., in press [31]). There is also evidence of lymphocyte cell aggregation 
within teleostian gill epithelium in salmon [32] and expression of IL-4, IL-13 and GATA-3 in 
trout and salmon gills which may be indicative of a TH2 response [33]. Macrophages appear 
to be the main APC in fish but dendritic-like cells (important APC in mammals) have been 
reported in some species [34-37]. Mammals have a diverse group of T cell subsets and in fish 
the expression of T cell receptors [38] has been shown in several species as well as functional 
studies showing the presence of different T cell types [34]. Phagocytic activity has been 
reported in B-lymphocytes in rainbow trout (Oncorhynchus mykiss) [39], Atlantic cod and 
Atlantic salmon (Salmo salar) [40]. In mammals, TH17 cells are a subset of CD4+ T cells 
which produce the proinflammatory cytokines IL-17A-F [41]. Interleukin-17 was discovered 
in normal and stimulated kidney, spleen, gills and intestine of zebrafish (Kono et al., in press 
[42]) and five member of the IL-17 receptor family (IL-17RA-RE) were found in the teleost 
genome [41]. Interleukin-21 from rainbow trout up-regulated in immune-related tissues and 
was induced by both bacterial and viral infection which suggest an importance in host defense 
[43]. Interferon- -10 and IL-22 which are signature cytokines for TH1, TH2 and TH17-type 
responses were expressed after stimulation with IL-21 in trout [43]. To date, T cell population 
subsets have not been identified in fish due to a lack of functional assays and antibodies [41]. 
The MHC class I molecules bind foreign peptides produced by the degradation of intracellular 
pathogens and present them to cytotoxic T cells whereas MHC class II molecules bind and 




Atlantic salmon the MHC consists of only one expressed classical MHC class I locus (Sasa-
UBA) and one classical class II alpha and class II beta haplotype (Sasa-DAA/DAB) [45]. The 
MHC class II has distinct class II haplotypes consisting of a combination of unique class II 
alpha and class II beta alleles [46]. Interestingly, Atlantic cod have not been shown to have 
MHC class II molecules [47] but are still able to produce an antibody response [48].  
Immunoglobulins (antibodies), a key humoral component of the adaptive immune 
system, are present in teleosts as flexible, loosely associated tetrameric IgM, compared to the 
pentameric mammalian IgM [29, 30, 34]. IgM can also be present in fish serum in relatively 
high concentrations as natural antibodies, as was shown for Atlantic cod [49]. The B cell 
recognition ability may be increased due to a number of low molecular weight 
immunoglobulins which have been isolated from several fish species [29]. The fish 
immunoglobulin IgT [50] (also known as IgZ [51]) has been discovered but its functional 
significance was not known until a study showed the unique structure and functions of IgT in 
its specialized role in mucosal immunity [52]. Some fish species have a poor response in 
terms of specific antibody production [49] but studies have shown the ability of numerous fish 
species to mount a strong and specific antibody response in reply to various antigens, vaccine 
and bacterial challenges [30, 53-57].  
1.2 Pathogen recognition receptors 
1.2.1 Toll-like receptors overview 
Toll-like receptors are PRR and key mediators of the innate immune system. They 
have been shown to recognize bacteria, fungi, protozoa and viruses and represent the host first 
line of defense sensing the invasion by pathogens and inducing the innate immune response [2, 
4, 58]. TLRs recognize structural components of microbes called PAMPs which are not found 
in the host and therefore behave as non-self (examples include LPS, flagellin, viral single and 
double stranded ribonucleic acid (ssRNA, dsRNA), etc). Table 2 shows the known ligands of 
TLRs in fish and mammals. The Toll gene was initially identified in Drosophila melanogaster 
for its importance in embryogenesis in establishing the dorsal-ventral axis [59] but has also 
been found to play a role in the fly's immunity against fungal infections [60]. The first 
mammalian TLR discovered was TLR4 and it was shown to activate nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kB) and the expression of inflammatory 
cytokines [61]. Later this TLR displayed hypersensitivity to LPS [62] and LPS was confirmed 




additional adapter proteins, but some, like TLR4 require the interaction of LPS to its binding 
protein, lymphocyte antigen 96 (MD2) before forming a heterodimer with CD14 [64]. Not 
only do TLRs play a key role in activating the innate immune response, they also control 
multiple dendritic cell functions and activate signals that are critically involved in the 
initiation of the adaptive immune response [65]. A recent study [66] showed TLR2, 3, 5 and 9 
ability to act as co-stimulatory receptors enhancing proliferation and/or cytokine production 
of T cell receptor-stimulated T lymphocytes, as well as the suppressive activity of CD4+ 
CD25high Treg cells by TLR2, 5 and 8. The field of TLR research is constantly revealing new 
discoveries which may prove to be important in developing immunotherapeutics for mammals 




Table 2. Known key ligands of TLRs in fish and mammals. Adapted from Palti (in press [67]).  
TLR Fish species                        Known ligands 
  Mammals Fish 
TLR1 Fugu, zebrafish Lipopeptide; Pam3CSk4 Unknown 





TLR3 Fugu, zebrafish dsRNA; poly I:C dsRNA, poly I:C 
TLR3a/b Common carp N/Aa Unknown 
TLR4 N/A LPS N/A 
TLR4b.a/b Zebrafish N/A Unknown 
TLR5 Fugu, rainbow trout Flagellin Flagellin 
TLR5b Fugu, rainbow trout N/A unknown 
TLR5S Fugu, rainbow trout N/A Flagellin 
TLR7 Fugu, zebrafish ssRNA; R848 Unknown 
TLR7a/b Common carp N/A Unknown 
TLR8 Fugu ssRNA Unknown 
TLR8a/b Zebrafish N/A Unknown 
TLR8a1/2a Rainbow trout N/A Unknown 
TLR9 Fugu, zebrafish CpG DNA Unknown 
TLR11 N/A Profilin N/A 
TLR14 Fugu, zebrafish N/A Unknown 
TLR19 Zebrafish N/A Unknown 
TLR20a Zebrafish, catfish N/A Unknown 
TLR21 Fugu, zebrafish N/Ab Unknown 
TLR22 Fugu, zebrafish N/A dsRNA; poly I:C 
TLR22a/b Atlantic salmon N/A Unknown 
TLR23 Fugu N/A Unknown 
a N/A- this gene has not been identified in this taxa group to date. 
b Recently, the chicken TLR21 was shown to recognize CpG DNA like the mammalian TLR9 [68].  
1.2.1.1 Structure of TLRs 
 TLRs are type I integral member glycoproteins characterized by a cytoplasmic 
signaling domain and extracellular domains. The cytoplasmic domain is similar to the IL-1 
receptor family and is therefore called the Toll/IL-1 receptor (TIR) domain. The extracellular 
domains are composed of leucine-rich repeats (LRR) each consisting of a - -
helix connected by loops (Figure 1) and they are responsible for binding to PAMPs [64, 69, 
70].  In human TLRs, the blocks of LRRs are usually bordered at the N and C termini by 
capping structures stabilized by disulfide bonds. Receptor cytoplasmic domains consist of a 




solved crystal structure is human TLR3 [72], but the following TLR-complexes have been 
solved; TLR1-TLR2 heterodimer [73], TLR4-MD-2 complex with bound endotoxin 
antagonist eritoran [74] and mouse TLR3-ectodomains and dsRNA [75]. With no TLR5 
structure solved the TLR5 ectodomain structure has been predicted to contain 20 LRRs, with 
five loops extending from the ascending or convex surfaces [76]. Ligand binding domains of 
TLR5 are described in chapter 1.4.2.  
                   
Figure 1. Overall architecture of TLR3 ectodomain in a ribbon representation. Adapted from 
Choe et al., 2005 [59]. 
The N-terminal cap region is colored blue; the 23 canonical LRRs are in green; and the C-terminal region is in 
pink. N-linked sugars (N-acetylglucosamines) that are observed in the electron density maps are shown in ball-
and-stick representation, attached to their respective Asn residues. The disulfide bond linking LRRs 2 and 3 is 
drawn in orange, adjacent to the glycosylation site. Side view of TLR3 shown with the convex face pointing 
outwards, the concave face inwards, and the heavily glycosylated side face pointing toward the viewer. Since the 
crystal structure of TLR5 is not solved yet, the TLR3 is chosen to give an impression of TLR architecture.  
1.2.1.2 Localization of TLRs 
A wide range of innate and adaptive cell types can express TLRs including 
macrophages, dendritic cells (DCs), B and certain types of T cells [77]. The distribution of 
TLRs on various fish cells have not been easy to perform since there is a lack of specific cell 
determinants. The two main locations of TLR expression are the cell surface or endosomal 
surface (Figure 2). TLRs expressed on the cell surface include TLR4, 5, 6, 2, 1 and 10 and on 
the endosomal surface include TLR3, 7, 8 and 9. Interestingly, when looking phylogenetically 
at the extracellular domain of human TLRs, there is a clear clustering into two broad groups, 
the TLRs that respond to bacterial stimuli (located on cell surface) and those that recognize 





described by Werling et al. [64], is that “the positive selection was highest in the domain 
involved in ligand binding while regions involved in heterodimerization were shaped by 
purifying selection. Therefore, amino acids responsible for TLR-PAMP ligand binding are 
highly diverse”.    
         
Figure 2. TLR ligands and signaling pathways. Adapted from http://www.invitrogen.com. 
1.2.1.3 TLR signaling- MyD88-dependent pathway 
TLR signaling is vital for the activation of both the innate and adaptive immune 
systems [65]. Initiation of TLR signaling pathways leads to the activation of the transcription 
factor NF- mitogen-activated protein kinases (MAPKs), p38 and c-Jun N-terminal 
kinases (JNK) which then culminates in the induction of inflammatory cytokines, chemokines 
and co-stimulatory molecules (Figure 2). Adapter proteins such as the myeloid differentiation 




domain used for binding to the TIR domain of liganded TLRs and a N-terminal death domain 
which engages the death domain of downstream target interleukin-1 receptor-associated 
kinase (IRAK) [4, 77]. There are five adapter proteins discovered but I will focus on MyD88 
due to its role in binding to TLR5 and because in general, it is known to bind to all TLRs 
except TLR3 [77]. Even though different ligands bind to a range of TLRs, they all engage the 
same adapter protein, but can activate distinct albeit overlapping genes. Some TLRs are 
completely dependent on one adapter protein and signaling pathway (TLR2 and TLR9), 
however, TLR4 is able to induce more than one type of adapter protein [4].  
Once the TLR binds to MyD88, the IRAK family is stimulated (IRAK1, IRAK2, 
IRAK4 and IRAK-M) [58, 77-79]. After phosphorylation, the IRAKs dissociate from MyD88 
and interact with TNF receptor associated factor 6 (TRAF6) which then associates with TGF-
 activated kinase 1 (TAK1), TGF-  activated kinase 1/MAP3K7 binding protein 2 (TAB2) 
or NF- inhibitor of NF-
complex (IKK) is activated and then phosphorylates the NF-  inhibitor ( ), inducing its 
degradation and the release of NF- ontrols the expression of various cytokines, 
chemokines, acute phase proteins and cell adhesion molecules for example, IL- -6, IL-8, 
CD80, CD86. The activation of TAK1 results in the activation of the MAPK pathways, p38 
and JNK. JNK activates a number of important transcription factors including c-Jun, 
activating transcription factor 2 (ATF-2), Ets Like gene1 (Elk-1) and the nuclear factor of 
activated T cells whereas the p38 triggers Elk-1 and ATF-2. The MAPK pathways also 
culminate in the expression of various important inflammatory cytokines and chemokines.  
1.2.1.4 TLR’s in fish 
Since the discovery of the first teleost TLR in goldfish stimulated macrophages [80], 
studies have been undertaken to elucidate TLRs role in the innate and adaptive immune 
systems of fish. The TLRs in fish share a number of similarities with their mammalian 
counterparts. Six major TLR families are present in all vertebrate taxa and they are shown as a 
phylogenic tree comparison of mammals and fish (Figure 3). These similarities may be due to 
strong selective pressure from pathogenic microbes which aided in preserving TLR 
recognition and signaling throughout vertebrate evolution [81]. Seventeen TLRs have been 
identified in more than a dozen teleost species (TLR1, 2, 3, 4, 5, 5S, 7, 8, 9, 13, 14, 18, 19, 20, 
21, 22, 23) [5, 28]. There are a few key differences such as the detection of novel TLRs found 
only in fish such as, TLR5S, 13, 20-23. To date, TLR6 and TLR 10 have not been found in 




contrast to the mammalian counterpart that detects only viral. TLR4 may have been lost in 
some fish species as it has yet to be identified in many species, or may function in the down-
regulation of TLR activity in others. Some argue that TLR4 has been lost in the genome of 
most fishes as TLR4 genes found in zebrafish do not recognize the mammalian agonist LPS 
and are likely paralogous, not orthologous to mammalian TLR4 (Palti, in press [67]). Sepulcre 
et al. [82] showed that LPS signaled via a TLR4- and MyD88-independent manner in fish and 
that the zebrafish (Danio rerio) TLR4 orthologs negatively regulated the MyD88-dependent 
signaling pathway which may help the fish resistance to endotoxic shock. Atlantic cod TLR’s 
are unique due to the absence of several TLR’s that recognize bacterial surface antigens 
(TLR1, TLR2 and TLR5) [47]. They do possess TLR14 and TLR18 which are teleost-specific 
members of the TLR1 family and expanded TLR’s that recognize nucleic acid (TLR7, TLR8, 
TLR9 and TLR22). This gives cod the highest number of TLR’s in teleost to date and points 
to an increased role in the cod immune system on nucleic-acid detection to recognize 
pathogens.  
Genome and gene duplications have contributed to the genomic diversity in fish (Palti, 
in press [67]. The distinct features and large diversity of teleost TLRs may have derived from 
their diverse evolutionary history and distinct environments in which they live. There are a 
number of duplicate multi-copy TLR genes identified including; TLR3 and 7 in carp, TLR4b, 
5, 8 and 20 in zebrafish, TLR8a in rainbow trout and TLR22 in rainbow trout and Atlantic 
salmon (Palti, in press [67]. To date, direct ligand specificity has only been shown for TLR2, 
TLR3, TLR5M, TLR5S and TLR22 (Palti, in press [67]. Little functional analysis has been 





Figure 3. Circular phylogenetic tree of all known full-length fish TLR amino acid sequences 
and the orthologue mammalian TLR amino acid sequences. From Rebl et al., 2010 [25].  
MEGA v3.1 [83] reconstructed a phylogenetic tree according to the Neighbor Joining method using the Poisson 
correction distance model. Only bootstrap values above 70% are indicated. The sequences were derived from 
Carassius auratus (TLR, accession number: AAO53555), Cyprinus carpio (TLR3, ABL11473), Danio rerio 
(TLR1, NP_001124065; TLR2, NP_997977; TLR3, NP_001013287; TLR4B, NP_997978; TLR5B, 
NP_001124067; TLR9, NP_001124066; TLR18, NP_001082819; TLR22, NP_001122147), Gobiocypris rarus 
(TLR3, ABL11471), Ictalurus furcatus (TLR3, ABH10661), Ictalurus punctatus (TLR2, ABD17347; TLR3, 
ABD93872; TLR5, ABF74618; TLR21, ABF74623); Larimichthys crocea (TLR9A, ACF60624; TLR9B, 
ACF60625), Oncorhynchus mykiss (TLR3, AAX68425; TLR5, BAC65467; TLR9, NP_001123463; TLR22, 
TLRI, CAF31506; TLR22L, TLRII, CAI48084), Paralichthys olivaceus (TLR2, BAD01044; TLR9, BAE80690; 
TLR22, BAD01045), Salmo salar (TLR5S, Toll-like leucine-rich repeat protein, AAV35178; TLR9, 
NP_001117125; TLR13, NP_001133860; TLR22A, CAJ80696; TLR22B, CAR62394), Sparus aurata (TLR9A, 
AAW81698TLR9B, AAW81699), Takifugu rubripes (TLR1, AAW69368TLR2, AAW69370; TLR3, 
AAW69373; TLR5, AAW69374; TLR5S, AAW69378; TLR7, AAW69375; TLR8, AAW69376; TLR9, 
AAW69377; TLR14, AAW69369; TLR21, AAW69371; TLR22, AAW69372; TLR23, AAW70378, Tetraodon 
nigroviridis (TLR1, ABO15772); Mus musculus (TLR11, AAS37672; TLR12, NP_991392; TLR13, 
NP_991389), and Homo sapiens (TLR1, NP_003254; TLR2, NP_003255; TLR3, NP_003256; TLR4, 
NP_612564; TLR5, NP_003259; TLR6, NP_006059; TLR7, NP_057646; TLR8, NP_619542; TLR9, 





1.2.1.5 TLR5 in fish- membrane bound and soluble 
TLR5 binds to flagellin which elicits recognition and response by the innate immune 
system [67, 84-86]. The types of TLRs found in fish are membrane-bound and soluble. 
Humans have the membrane-bound form of TLR5 but are lacking the soluble ortholog that 
has been found in fish such as pufferfish (Fugu rubripes) [87], rainbow trout [88], Atlantic 
salmon [89] and Japanese flounder (Paralichthys olivaceus) [90]. The membrane-bound form 
of TLR5 (TLR5M) consist of an extracellular domain containing leucine-rich repeats (LRRs), 
a transmembrane region and a cytoplasmic signaling domain, called the TIR domain whereas 
the soluble form of TLR5 (TLR5S) contains only the extracellular LRR domain [87, 88]. 
Rainbow trout TLR5M was shown to be ubiquitously expressed (muscle, testis, gill, stomach, 
intestine, kidney, heart, spleen, brain and liver) whereas TLR5S was predominantly expressed 
in the liver [88]. The organ expression distribution appears to vary between fish species as 
TLR5S in catfish was mainly expressed in the liver but was also present in the head kidney, 
spleen, gills, skin, ovary and brain [91]. A microarray study of Atlantic salmon infected with 
Aeromonas salmonicida showed up-regulation in the liver of an EST corresponding to the 
extracellular region of TLRs and most similar to TLR5 of rainbow trout and the TLR5S of 
pufferfish (Takifugu rubripes) [92]. Interestingly, both soluble and membrane-bound forms of 
TLR5 are absent in Atlantic cod [47].  
Tsujita proposed that flagellin first induces the basal activation of NF-
facilitating the production of TLR5S which then amplifies TLR5M cellular responses in a 
positive feedback loop which would enhance the innate immune response in fish [88]. When 
the TIR domain of human TLR5 is connected to the C-terminal end of TLR5S from rainbow 
trout (rtTLR5S) they signal the presence of flagellin which suggest that rtTLR5S recognizes 
flagellin in the fluid phase. Therefore the flagellin recognition properties of TLR5S are 
conserved along with the NF- [86]. 
1.2.2 Nod-like receptors (NLR) 
1.2.2.1 Overview 
A new type of intracellular PRR has been discovered and is an exciting area of 
research for the innate immune system. The nucleotide-binding domain and leucine-rich 
repeat-containing family (NLR) are cytoplasmic receptors that are involved in regulating NF-
-  [93]. In humans 22 NLR proteins have been 




protein-protein interaction domain, a central NOD and a central leucine-rich repeat that 
detects PAMPs [93, 94]. In mammals NLRs are primarily expressed in immune cells 
(lymphocytes, APCs such as macrophages and DCs) but they can also be expressed in non-
immune cells (such as epithelial and mesothelial cells) [93].  
1.2.2.2 Naip5 and NLRC4 
Recent studies in mice and humans describe two NLRs, NLR family caspase 
activation recruitment domain (CARD) domain-containing protein 4 (NLRC4) and neuronal 
apoptosis inhibitory protein 5 (Naip5), that are able to bind to cytosolic flagellin and 
contribute to the activation of the inflammasome and an inflammatory response, including 
caspase-1 and NF- [95]. The Naip5 receptor specifically recognizes 35 amino 
acids at the carboxyl terminus of flagellin to trigger inflammasome activation [96]. The NLRs 
involved in flagellin recognition have not yet been identified in fish. Little research has been 
done on NLRs in teleost fish but NLRs have been identified in zebrafish, [97], channel catfish 
(Ictalurus punctatus, [98]) and grass carp (Ctenopharyngodon idella, [99]) and could prove to 
be important in the flagellin dependent immune response in salmonids.  
1.4 Flagellin 
1.4.1 Overview and Structure 
Flagellin is the structural protein that forms the major portion of the flagellar filaments 
that contribute to virulence through chemotaxis, adhesion to and invasion of host surfaces 
[100, 101]. The bacterial flagellum is a locomotive organ that enables bacteria to swim by 
rotating a filament that is powered by a proton-driven rotary motor [102]. The flagellum is 
made up of three main parts; basal body (the motor), torsion hook and the helical hollow 
filament. Flagellar filaments are composed of 11 protofilaments which wrap around each 
other to form the filament. The filament is a tubular structure that is composed of up to 30 000 
units of flagellin [102] and each flagellin protein ranges in size from 28-80 kDa [100]. There 
are four main globular domains (D) of the flagellin monomer (Figure 4). The D0 regions are 
conserved N- and C- -helical structures that flank the 
central region and are positioned in the filament core along with the D1 region. The D1 region 
-helical structures, is highly conserved and known to be involved in 
TLR5 signaling. The D2 and D3 regions are hypervariable (in residue composition and size) 




The first structure of flagellin that was crystallized was the F41 fragment (missing 52 
N- and 44 C-termini residues) of Salmonella typhimurium [104]. Due to flagellin’s strong 
tendency to polymerize, it has been difficult to crystallize which was why the N- and C-
termini residues were removed. More recently, a cell-surface flagellin from Sphingomonas sp. 
was crystallized bound to a polysaccharide and results showed that residues 20-40 and 353-
363 were responsible for alginate binding [105]. Both structures were solved at 2.0-Å 
-helical D1 domains -domain.  
                     
Figure 4. Structure and organization of flagellum and flagellin * Adapted from: Ramos et al., 
2004 [100], Honko and Mizel, 2005 [106].  
Flagella structures protruding from bacteria comprise a hook (dark green) and a filament, referred to as a 
flagellum (yellow). Schematic transversal and longitudinal views of the flagellum and ribbon diagram of the C
backbone of flagellin from Salmonella enterica serovar Typhimurium. The flagellin domains are colour coded as 
- -helix chains (D1, blue), and the hypervariable 
-sheets (D2 and D3, yellow). The concentric circles on the end-on view show the organization of 
-helix regions (purple and blue), necessary for filament architecture and 
motility functions, are embedded in the flagellum inner core. Flagellin monomer is the molecular pattern that is 
detected by innate receptors. In the monomer, flagellin D0 terminal chains are totally disordered, whereas the D1, 
-helix chains of D1 domain (blue rectangle) are required 




1.4.2 Binding to TLR5 
 The recognition and binding of flagellin to TLR5 is known to occur in many species 
and produce both innate and adaptive immune responses. In 2003, two studies reported the 
location of the binding site on flagellin that recognizes TLR5. Jacchieri et al. [107] used a 
search for complementary hydropathy between the sequences of TLR5 and flagellin to predict 
the binding site location to the 88-97 chain fragment of flagellin (S. enterica) which is located 
Using deletional, insertional and alanine-scanning mutagenesis, Smith et al. 
[103] mapped the location of the TLR5 recognition site on flagellin to a cluster of 13 amino 
acid residues in the D1 domain that participate in intermolecular interactions within flagellar 
protofilaments and that are required for bacterial motility. Filamentous flagellin reduced 
TLR5 stimulatory activity by 96% compared to that of the monomeric form. This could be 
due to the D1 domain being buried in polymerized filamentous flagellin and exposed in 
monomeric flagellin, which suggest that TLR5 recognizes flagellin monomers that are 
released on depolymerization of flagellin polymers [103]. Flagellin was also shown to co-
precipitate with TLR5, indicating a close physical interaction between the protein and 
receptor [103]. The location of the TLR5 binding site was examined using truncation studies 
that demonstrate that the flagellin-binding site in TLR5 is located between residues 386 and 
407, placing it in LRR14 [108]. The sequence of LRR14, which is 32 residues in length, 
reveals a six-residue insertion after position 15. Based upon the truncation data, it is probable 
that this insertion contributes to flagellin binding [76].  
1.4.3 Immune response to flagellin 
 Flagellin is the only known TLR PAMP that is purely protein, which allows for 
research into its specific immune responses and for its manipulation for use in adjuvant 
research. Mammalian TLR5 has been shown to recognize both gram-positive and gram-
negative bacterial flagellin and activate the NF- -  [109]. In 
MyD88 positive mice stimulated with flagellin, the animals were shown to produce IL-6 but 
MyD88 knock-out mice did not respond to flagellin stimulation [109]. This provides evidence 
of the innate immune response to flagellin and the signaling pathways involved. Numerous 
studies in mammals have tested the adjuvant abilities of flagellin, as fusion proteins (flagellin 
bound to an antigen) or flagellin and the antigen used separately (reviewed in [84]). Flagellin 
is able to promote important innate immune processes which are vital to the development of 




chemokines by lymphoid and non-lymphoid cells, the generalized recruitment of T and B 
lymphocytes to secondary lymphoid sites, DC activation and direct activation of T 
lymphocytes [84]. In mice, co-administration of monomeric flagellin expressed in 
Escherichia coli or polymeric flagellin isolated from Salmonella with inactivated influenza 
virus resulted in production of specific antibodies titers, that induced full protection against 
highly lethal challenge by homologous virus (in comparison to partial protection from 
unadjuvanted inactivated virus) and proinflammatory cytokine production (IL-4, MIP-2, 
- [110]. A fusion protein vaccine containing type A and B flagellin 
proteins linked to the outer membrane proteins OprF and OprI from Pseudomonas aeruginosa 
were successful in clearing mice of non-mucoid P. aeruginosa and elicited robust antigen and 
flagellin specific IgG responses in mice and African green monkeys [111, 112].   
 The use of flagellin for vaccines or immunostimulants has not been widely studied in 
fish. A study in salmon tested recombinant subunit vaccines produced from Piscirickettsia 
salmonis for protection from rickettsial septicaemia [113]. Three different combinations of 
recombinant proteins (including different flagellin proteins) were emulsified with Freund’s 
incomplete adjuvant (FIA) and tested for efficacy. The highest relative survival (95%) was in 
the vaccine that included the flagellar protein FlgG and two heat shock proteins (Hsp60 and 
Hsp 70) [113]. The results suggest that not all flagellin proteins produce the same protective 
immune response and that the combination of proteins in the vaccine formulation may be 
important. McGee et al. [114] showed that like the flagellin protein FlaA, FlaD and FlaE also 
showed evidence of being involved in the virulence of Vibrio anguillarum. It is possible that 
the roles the protein plays in the bacterium may give clues to the immune response produced 
when injected into host species. A study in red snapper (Lutjanus sanguineus) vaccinated with 
the recombinant protein FlaC from Vibrio alginolyticus showed the production of specific 
antibodies and high resistance to infection by V. alginolyticus [115]. Jiao et al. have studied 
the immunoprotectivity of the FliC from Edwardsiella tarda in both recombinant protein and 
as a DNA vaccine constructs injected into Japanese flounder [116, 117]. They found that the 
most promising vaccine candidate was a chimeric DNA vaccine of the antigen Eta6 or Et18 
fused in-frame to FliC. These constructs produced significantly higher levels of protection 
than just the antigen alone as well as serum specific antibodies and genes involved in innate 




1.5 Vaccines in Aquaculture 
1.5.1 Overview 
Vaccination is the administration of antigenic material to stimulate an adaptive 
immune response. Vaccines can prevent or ameliorate the effects of infection by a pathogen. 
The use of vaccines in aquaculture has caused the decreased use antibiotics and losses 
associated with disease [1, 118]. This has allowed for a three-fold increase in fish production 
from 1985 to 2003 in the Norwegian aquaculture sector [1]. It is estimated that 10% of all 
cultured aquatic animals are lost due to infectious diseases which amounts to a global loss of 
8-10 billion USD annually [119]. While a number of effective bacteria vaccines are available 
for many fish species, there is still a need for more efficacious viral and parasite vaccines. 
Recent advances in fish genomics and proteomics have opened new avenues for research into 
novel vaccines.   
1.5.2 Administration  
 Fish can be vaccinated by injection, immersion or orally. The easiest method to use is 
oral vaccination whereby the antigen is included in the feed. However this method has had 
poor and inconsistent results due to antigen degradation in the gut and requires more 
advanced delivery methods such as poly-(lactic-co-glycolic) (PLG) formulations, liposomes 
or alginate beads [1, 120]. Immersion of the fish in a diluted vaccine solution is easy for small 
fish and provides good protection for live, attenuated vaccines, but less for inactivated 
vaccines. This method is easy but can be cost prohibitive due to the large amount of vaccine 
needed. The highest level of protection comes from injection vaccination whereby the vaccine 
is injected into the body cavity of the fish. This method requires a smaller amount of vaccine 
therefore can be cost effective and each fish is injected with the same amount of vaccine. The 
challenge with this method is that it is a labor-intensive process, stressful for the fish and the 
fish must be over a certain size [1, 119, 120].  
1.5.3 Vaccine types 
 Currently, the most used type of vaccine in the aquaculture industry is the inactivated 
vaccine. PHARMAQ are worldwide producers of fish vaccines and have developed a multi-
valent inactivated vaccine that is effective against furunculosis, vibriosis, coldwater vibriosis, 
winter sore and IPN1. This multi-valent vaccine had annual sales for salmon reported in July 
                                                 




2010 of 236 million doses and this is expected to be much higher for 20112. PHARMAQ also 
have other inactivated vaccines available for the following diseases; pancreatic disease, 
infectious salmon anemia (ISA), salmonid rickettsial septicaemia, pasteurellosis and flavo 
bacteriosis2.  This type of vaccine is advantageous because it is cost-effective, easy to produce 
and has shown to be very effective in a number of bacterial diseases. A study testing the 
efficacy of oil-adjuvanted inactivated vaccines from V. anguillarum and A. salmonicida in 
Atlantic cod showed high levels of protection against homologous challenge with 94 and 77% 
relative percent survival (RPS) respectively [121].  
Live attenuated vaccines are created by reducing the virulence of a pathogen, altering 
it so that it becomes harmless or less virulent [122]. This type of vaccine has potential for use 
in aquaculture but there are a number of safety concerns present, such as persistence in the 
fish and the environment, reversion to virulence and risk of spreading to non-target animals 
[120]. Attenuated vaccines have been successful for some bacterial and viral diseases (ex, 
infectious hematopoietic necrosis virus, IHNV) but they still have problems with safety issues 
and government restrictions [1], therefore none are currently commercially available in 
Norway.  
DNA vaccines contain a genetically engineered, small, circular piece of DNA (plasmid) 
that is injected into a host to produce one or two specific protein antigens from a pathogen in 
order to elicit an immune response [123]. Nucleic acid vaccines have many characteristics 
that make them superior to classical vaccines. Among these characteristics are vaccine 
stability at ambient environmental temperatures, thus removing the necessity for a cold chain 
for vaccine storage, lack of any living organism in the formulation, removal of the possibility 
of reversion of that organism to pathogenic status and the lack of tissue damaging adjuvants 
[124]. This treatment has been shown to be effective against a number of viruses including 
channel catfish virus [124], viral hemorrhagic septicemia (VHS) [125] and IHNV [126], 
infectious pancreatic necrosis virus (IPNV) [127] and the bacterium Renibacterium 
salmoninarium [128]. DNA vaccines use is limited due to governmental regulations and 
safety risks, such as, the integration into chromosomal DNA, pathological processes at the site 
of infection, distribution to internal organs and longevity of retention of foreign DNA in these 
organs [119, 123, 129].  
Recombinant subunit vaccines contain specific recombinantly produced protein 
antigens and are therefore advantageous from a safety point of view as they cannot invade the 
                                                 




host genome or replicate in the environment. They can be difficult to produce as is the case 
for a number of viral membrane antigens and generating the correct monomeric conformation 
can be a challenge. There have been problems associated with effective protection from 
subunit vaccines against IHNV most likely due to incorrect folding of the expressed proteins, 
but promising results in combating IPNV [129, 130]. There are no commercial DNA or 
subunit vaccines currently available in Norway but research is underway to develop more 
effective and safe formulations.  
1.5.4 Use of microarray in fish vaccine studies 
 The profiling of immune responses during fish vaccination is in its infancy and there 
are only a few numbers of scientific attempts that have addressed direct molecular correlates 
of protection other than antibody responses and up-regulation of certain transcripts. To find 
molecular signatures that may be acknowledged as correlates of protection one should not 
only analyze single genes but also assess transcriptomics [131]. There may be molecules that 
have no apparent immunological function but probably is quite involved in disease protection 
[131]. In recent years, cDNA microarrays have been developed for species such as, zebrafish, 
salmonids, catfish, sea bream, halibut and Atlantic cod. They can be used for investigations 
on cell biology, reproduction, nutrition, physiology, stress, effects of environmental pollution 
and immunology [132, 133]. Transcriptomics is emerging as a powerful tool in the 
development of effective vaccines in the aquaculture industry. Both immune-related genes 
and genes not known to be involved in the immune response can simultaneously be measured 
to provide a broad view of the response seen in fish. The use of microarrays for this purpose 
has not been done in a large number of studies. To my knowledge, there is only one study that 
has addressed the “correlates of protection” issue in fish. A study that investigated low and 
high resistant salmon that were vaccinated and challenged by A. salmonicida concluded that 
the efficiency of vaccination against furunculosis depends largely on the ability of host to 
neutralize the negative impacts of immune responses combined with efficient clearance and 
prevention of tissue damages [134]. They were able to use microarray and QPCR to determine 
the mechanisms involved in resistance to the disease and the specific genes that had marked 
expression differences between high and low resistance that can be considered as positive and 
negative correlates of vaccine protection against furunculosis. A review paper by Aoki et el 
[135] outlines microarray studies that were successful in measuring differences in responses 
of viral and bacterial vaccinated fish and highlights the importance of this technique for the 





The term adjuvant stems from the latin word “adjuvare” meaning to help and its role 
in vaccine development is dependent on its ability to stimulate or prime the immune system 
[136]. This allows for a more efficient and effective response to the antigen. Many of the 
vaccines currently available for salmon are inactivated vaccines which are preferred due to 
safety but they tend to lack immunogenicity and therefore require the use of adjuvants [119]. 
Generally, adjuvants function in several ways including; (1) increasing the immunogenicity of 
weak antigens, (2) enhancing the speed and duration of the immune response (depot effect), 
(3) modulating antibody avidity, specificity, isotype or subclass distribution, (4) stimulating 
CTL, (5) promoting the induction of mucosal immunity, (6) enhancing immune responses in 
immunologically immature or senescent individuals, (7) decreasing the dose of antigen in the 
vaccine to reduce costs, (8) helping to overcome antigen competition in combination vaccines, 
(9) improve antigen presentation and (10) reduce need for booster immunizations [136-138]. 
Many of the vaccines used for fish use oil-based adjuvants but in humans, oil adjuvants 
cannot be used due to severe side-effects therefore aluminum-based adjuvants are used which 
despite poor adjuvanticity, are safe and produce a TH2 biased response [139].  
Promising results using flagellin as an adjuvant have been shown in previous research 
in mice [110, 111, 140-142], monkeys [112] and Atlantic salmon [113] which demonstrated 
effective immune responses and increased survival in challenge studies during and after 
flagellin treatment. Flagellin is also an attractive candidate for use in human vaccines as was 
shown in a recombinant hemagglutinin influenza-flagellin fusion vaccine in elderly patients 
[143]. It is effective at very low doses, does not promote IgE responses, prior immunity to 
flagellin does not impair its adjuvant activity, antigen sequences can be inserted at the amino 
or C terminus or within the hypervariable region of the protein without any loss of flagellin 
signaling via TLR5, has no detectable toxicity in rabbits when given intranasally or 
intramuscularly and it can easily be made in fairly large amounts under good manufacturing 
practices conditions [84].  
1.5.5.1 Modes of action 
Despite many years of research into the mode of action of adjuvants, little is currently 
known. Janeway has referred to adjuvants as “immunology’s dirty little secret” due to the 
inability of antigens to induce a robust immune response in the absence of an adjuvant [144]. 
Understanding how adjuvants function is key to producing more specific vaccine components 




propensity for adverse side-effects from oil-based adjuvants, focus has been placed on TLR 
agonists as new candidates for adjuvants. The activation of TLRs directs an increased number 
of innate immune cells at the infection site, along with production of proinflammatory 
cytokines and chemokines, resulting in the induction of antigen-specific adaptive immune 
responses [65].   
There are three types of adjuvants which can induce three signals either alone or in 
combination and they are described by Barr et al. [139] and Guy [136] and shown in Figure 5. 
Signal 0 is induced mostly through the recognition of PAMPs by PRRs and increases antigen 
uptake and presentation by APCs. Signal 1 is activated by specific recognition of peptides 
presented by MHC II molecules to the TCR and improves antigen presentation, but must be 
accompanied by a co-stimulatory signal to prevent anergy. Signal 2 is the co-stimulatory 
signal with the receptor-ligand interaction occurring between APCs and T-cell antigens. Type 
A adjuvants can act on signal 0 and indirectly on signal 2 to activate APCs and induce 
secretion of cytokines. Type B adjuvants target APCs or favor antigen capture and they act 
solely on signal 1. Adjuvants that directly stimulate signal 2 are type C and are specific 
ligands of co-stimulatory molecules. TLRs are special in being able to stimulate all three 
modes of action for adjuvants and are therefore of high interest for adjuvant research.  
 
Figure 5. Where do adjuvants act? From Guy [120]. 
The initiation of T helper cell responses requires three signals; signal 0, signal 1 and signal 2. In theory adjuvants 
can act alone or in combination on each of these three signals and an adjuvant acting on each signal is shown. 
Some specific adjuvants, such as TLR agonists, can be considered as type A adjuvants: they act on signal 0, and 
indirectly on signal 2, by activating APCs and triggering the secretion of cytokines. TLR agonists can act on 
signal 1 by favoring efficient presentation of the co-administered antigen. Some TLR agonists also directly 
trigger signal 0 on regulatory T cells and B cells expressing some of the corresponding receptors. Adjuvants 
targeting APCs or favoring Ag capture can be viewed as type B adjuvants acting on signal 1, as their effect is 
eventually mediated by enhanced Ag presentation to T cells. Targeting signal 1 is not sufficient and an 
immunostimulatory signal should be co-delivered for an optimal response. Some specific ligands of co-
stimulatory molecules can directly enhance signal 2, acting as type C adjuvants; such compounds must however 





Problems associated with adverse adjuvants effects are well known in vaccine design 
and have been shown to occur in numerous fish species following vaccination with oil-based 
vaccines. Midtlyng and Lillehaug [145] showed that salmon injected into the intraperitineum 
with oil-adjuvanted vaccines had retarded growth which was associated with increased 
severity of abdominal lesions. A series of studies by Mutoloki et al. of oil-adjuvanted 
vaccines have further elucidated the adverse reactions seen in salmon, rainbow trout and 
Atlantic cod. Briefly, oil adjuvants must be injected with antigen to produce a strong 
inflammatory reaction [146] and persistent antigens at the injection site perpetuate the 
inflammatory reaction, leading to adverse side-effects, including granulomas and intra-
abdominal lesions [55, 147-149].  A study involving the comparison of aluminum and FIA in 
Japanese flounder showed that while the FIA resulted in higher percent of survival, more 
severe intra-abdominal adhesions were also produced [150]. The consistent development of 
side-effects in bony fish after administration of oil-adjuvanted vaccines highlights the need 
for more sophisticated adjuvants in the aquaculture industry. Autoimmune responses have 
also been attributed to the use of oil-adjuvants or/and formulation [151-153]. 
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2. Aims of Study 
Many vaccines currently on the market include oil-based adjuvants that are known to 
cause adverse side-effects in fish. There is a need for new adjuvants which can provide 
effective immune system stimulation with minimal negative effects. The general purpose of 
this study was to produce recombinant flagellin for examination of the innate immune 
response after immunization of Atlantic salmon.  
 
The major aims were: 
1. To clone, express and purify recombinant flagellin from Vibrio anguillarum.  
2. To produce a polyclonal flagellin antibody. 
3. To assess in vitro NF- -7 cells after stimulation with flagellin. 
4. To examine the immune response of Atlantic salmon after injection with flagellin by 
ELISA, QPCR and microarray.  
5. To examine the immune response of Atlantic salmon after injection with a 
combination of flagellin and a model antigen (LPH or OVA).
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3. Abstract of papers 
Paper I. Immune response of Atlantic salmon to recombinant flagellin  
 
Many viral vaccines used in aquaculture are unable to stimulate an appropriate level of 
immunity to withstand infection. By targeting specific components of the immune system it 
may be possible to trigger stronger, more effective responses to antigens. Flagellin has the 
ability to stimulate both the soluble and membrane-bound forms of toll-like receptor 5 (TLR5) 
in salmon leading to a proinflammatory response and activation of both the innate and 
adaptive immune system. In this study flagellin (FlaD from Vibrio anguillarum) was 
recombinantly produced in two forms, full-length (FDL) and a truncated form (FDS) with 
portions of the N- and C-termini removed to prevent polymerization. FDS was used to 
produce an antibody that was able to bind both forms of flagellin in immunoblot analysis. In 
cell culture using COS-7 cells, FDL was shown to stimulate the NF- B pathway more 
effectively than FDS. Both forms of flagellin were used as an adjuvant with the antigen LPH 
(Hemocyanin from Limulus polyphemus hemolymph) in an immunization dose response study. 
FDS and FDL stimulated the innate immune system of salmon inducing proinflammatory 
-6, 
IL-8, and IL- -regulated (p<0.05) in the spleen. TLR5S was more 
highly up-regulated than TLR5M indicating that the soluble form of TLR5 may play an 
important role in the innate immune response in salmon. ELISA analysis showed that the use 
of flagellin as an adjuvant with LPH was not able to significantly induce flagellin or LPH 
antibodies. This study shows that flagellin has the potential to be a highly effective adjuvant 


















Paper II. Functional Genomics Analysis of the Immunological Responses of Atlantic 
salmon (Salmo salar) Spleen to Injection with Recombinant Flagellin from Vibrio 
anguillarum 
 
 The use of vaccines in salmon aquaculture has been successful in controlling many 
diseases in the industry and has aided in the decreased use of antibiotics. There are still 
challenges in creating vaccines against diseases caused by intracellular pathogens therefore a 
need exists for new vaccine components and adjuvants. Flagellin has been focused on in 
mammalian research because of its important role in binding to the innate immune receptor 
TLR5 and has produced promising results in vaccine studies. This study was conducted to 
examine the effect of intraperitoneal injection of recombinant flagellin on Atlantic salmon 
spleen transcript expression using DNA microarray hybridizations and QPCR. Four injections 
were compared: FlaD (purified recombinant FlaD protein from Vibrio anguillarum), 
FlaD+OVA (combination of FlaD and ovalbumin protein), OVA (ovalbumin alone) and 
saline control. The design of the microarray experiment used a pooled RNA approach to 
identify transcripts that were reproducibly differentially expressed in FlaD, OVA or 
FlaD+OVA compared with saline injected controls 2 days post injection (2DPI) or 7DPI. 
These time points allowed an expression analysis of innate defence genes. Some genes 
exhibited early, delayed or extended response over the sampling time and flagellin seemed to 
be the key component to eliciting a response.  Microarray results showed that flagellin 
injection caused significant up-regulation of inflammatory cytokines, chemokines and 
receptors (IL-8, TNFRSF11B, IL-1R), antimicrobial peptides (hepcidin, cathelicidin), 
complement genes (complement component C7 and C7-1), immune genes (C/EBP, 
thioredoxin, C-type lectin receptor B), peptidases (MMP-9) and genes involved in the 
Ras/MAPK pathway (Ras-related protein, Ras protein activator) in salmon. Down-regulation 
occurred in some important immune genes (LITAF, Mx1 and clusterin-1). A selection of up-
regulated genes from the microarray studies was also validated by QPCR using individual 
samples to assess biological variability. Flagellin was shown to induce the innate immune 







 The search for effective adjuvants for the aquaculture industry is an important area of 
research in vaccine design. Improved adjuvants could aid in the immune response to increase 
survival while minimizing adverse side-effects. Flagellin is a pathogen-associated molecular 
pattern (PAMP) that is known to stimulate toll-like receptor 5 (TLR5) to initiate an innate 
immune response [67, 84-86]. Much of the recent focus has been placed on flagellin in 
vaccine studies with many promising results [110-113, 140-142]. This thesis was the first to 
inject purified soluble recombinant flagellin protein into Atlantic salmon and study the 
immune response by microarray and QPCR analysis.  
 In paper I, two forms of soluble recombinant flagellin protein were produced; a 
truncated form (FDS) to avoid polymerization and a full-length (FDL) form. Both were used 
in a luciferase reporter gene assay to evaluate binding and activation of nuclear factor kappa-
light-chain-enhancer of activated B cells (NF- ) response with FDL showing a higher 
response than FDS. As FDS was easier to produce recombinantly, it was selected for antibody 
production in rabbit and the antibody was shown to bind to both forms of flagellin in 
immunoblot analysis. A dose response study was performed with Atlantic salmon injected 
intraperitoneally with two forms and doses of flagellin and hemocyanin from Limulus 
polyphemus hemolymph (LPH) as the antigen. Spleen samples were analyzed for mRNA gene 
expression using quantitative real time polymerase chain reaction (QPCR) with focus on 
innate immune genes. Enzyme-linked immunosorbent assay (ELISA) was performed to 
measure the anti-flagellin and anti-LPH antibody response, with low antibody levels 
measured in all groups tested. Several important innate immune genes were significantly up-
regulated by flagellin and the inclusion of the antigen LPH extended the response of some 
cytokines.  
 Based on the results from paper I, the truncated form of flagellin (FDS) was used in 
paper II (FlaD). FlaD was injected intraperitoneally into salmon and spleen samples taken 2 
days post injection (DPI) and 7DPI. With 27,917 Atlantic salmon and 4,065 rainbow trout  
cDNA features, the consortium for Genomic Research on All Salmonids Project (cGRASP) 
32K salmonid complementary DNA (cDNA) microarray [154] allowed for further exploration 
of a variety of genes. Flagellin alone and in combination with the model antigen ovalbumin 
(OVA) were injected into the peritoneum of salmon and this resulted in numerous immune 
response genes reproducibly up-regulated. Some genes exhibited early, delayed or extended 




response. Microarray results showed that flagellin caused significant up-regulation of 
inflammatory cytokines, chemokines and receptors, antimicrobial peptides, complement genes, 
peptidases and genes involved in the Ras/MAPK pathways. Down-regulation occurred in 
some important immune genes, such as Mx1, clusterin 1 and LITAF. Microarray gene lists 
were validated using QPCR of selected genes from the microarray results.  
 
 The results of the present study are discussed thoroughly in papers I-II. Selected topics 
will be discussed further here. It should be noted that due to difference in the abbreviations 
used between papers, in this discussion samples days will be referred to as days post injection 
(DPI) and flagellin proteins are truncated (FDS) and full-length (FDL) as in paper I and as 




4.1 Recombinant production of flagellin protein 
 In flagellated bacteria, flagellin is an important structural protein in the locomotive 
organ flagellum. It is important in subunit vaccine research due to its role in binding to the 
pathogen recognition receptor (PRR) TLR5, which causes an increased immune response in 
mammals and fish [67, 84-86]. Producing a purified form of flagellin from fish pathogens is 
key to investigating the immune response in salmon. The flagellum is composed of multiple 
flagellin proteins (e.g. FlaA, FlaE, FlaD), which vary in size, function and number of flagellin 
proteins between species. Two fish pathogens were used in this study; V. anguillarum 
(causing classical vibriosis) and Aliivibrio salmonicida (renamed from Vibrio salmonicida) 
(causing cold water vibriosis). All of the flagellin proteins (FlaA-E from V. anguillarum and 
FlaA-F from A. salmonicida) began the trial in both full-length and truncated forms from each 
species of bacteria. Truncated forms of the flagellin proteins with portions of the N- (1-47) 
and C- (337-377) termini removed, were chosen for expression based on the first successful 
crystallization of flagellin [104] which used a truncated form of the Salmonella typhimurium 
flagellin protein to avoid polymerization of the protein aiding in the production of crystals. 
There were proteins from both pathogens and of both lengths that expressed successfully in 
Escherichia coli BL21 (DE3) cells harboring pET151/D TOPO flagellin constructs in 
expression trials but FlaD  from V. anguillarum was chosen for injection trials due to its role 
in virulence and adhesion [114] and because both the full-length and truncated forms of FlaD 
expressed in soluble forms.  
There were some challenges associated with protein expression trials. When expressed 
at any temperature above 15 C, the proteins were produced in insoluble form so the 
temperature used for greatest production in soluble form was 13 C. A. salmonicida flagellin 
genes were more difficult to clone than genes from V. anguillarum. The A. salmonicida genes 
(full-length flaE, flaB and truncated flab) either did not express or expressed in low amounts 
in insoluble form, and were therefore not used in the study. Any protein used for vaccines in 
aquaculture should be relatively easy and inexpensive to produce. In comparison, seven V. 
anguillarum flagellin genes (truncated flaB, truncated flaA, full-length flaC, truncated and 
full-length flaE and truncated and full-length flaD) from both full-length and truncated forms 
had successful cloning and all could be seen using SDS-PAGE analysis after expression. The 
full-length FlaD protein (FDL) produced at lower amounts than the truncated form and 
problems were seen with stability during storage. In an unpublished degradation trial, both 




analysis. Results showed that FDS was highly stable at both temperatures over the 6-week 
trial whereas FDL degraded at both storage temperatures. Also, when FDL was concentrated 
over 1 mg/ml polymerization or precipitation into the insoluble form occurred.  
Having a recombinantly produced and highly purified flagellin protein from V. 
anguillarum provides a tool for various fish immunological studies. Having the crystal 
structure of this important PAMP would aid in understanding how flagellin binds to TLR5 
and the conformational changes that can occur. Highly purified (>95% estimated by SDS-
PAGE analysis) recombinant FDS was submitted to The Norwegian Structural Biology 
Centre (NorStruct) for crystallization trials. Numerous buffers (varying in solution 
components, pH, salt concentration, etc) were tried for crystal production but no usable 
crystals were produced for crystallization trials (unpublished results).  
Due to the ease of producing recombinant FDS, it was selected for polyclonal antibody 
production in rabbit and is referred to as pAb FDS. In immunoblot analysis, pAb FDS was 
shown to work effectively as an antibody, binding specifically to purified and unpurified FDS 
and FDL while not binding to other proteins tested. Further work should be performed to test 
pAb FDS in immunohistochemistry as well as accessing its ability to recognize other flagellin 
proteins (from V. anguillarum and other bacterial strains) in immunoblot analysis.  
4.2 Flagellin-antigen interactions 
In both papers, the experiments examined the immune response in the spleen after 
injection into Atlantic salmon of recombinant flagellin mixed in solution with a protein 
antigen; LPH in paper I and OVA in paper II. Hemocyanin from the horseshoe crab Limulus 
polyphemus is among the largest respiratory proteins found in nature ((3.5 MDa) [155]) and 
has been shown to induce an antibody response when injected into the peritoneum of salmon 
when conjugated to the hapten 4-hydroxy-3-iodo-5-nitrophenyl-acetic acid (NIP) [156], 
trinitrophenyl-acetic acid (TNP), fluorescein-5-iso-tricyanate (FITC) or alone [57, 157]. 
Ovalbumin (45 kDa [158]) is the major protein found in avian egg white and has been used as 
an antigen in numerous vaccine studies where it has been shown to induce antibody 
production and inflammatory cytokines in mice [159-163]. Ovalbumin is hydrophobic in 
solution which leads to protein aggregation [164] and protein aggregates have been shown to 
enhance immune responses over the monomeric form of the protein [165]. Since OVA has 
been widely used as a model antigen in vaccine trials of mammalian species [159-163] and 
due to the lack of antibody response with LPH in paper I, OVA was chosen as the antigen in 




flagellin+LPH injected salmon. This may be due to the tendency of antibody responses in fish 
studies to vary and to not always infer to immune response or survival in challenge studies 
[29]. Antigen competition [57, 157] could have played a role in the lack of antibody response 
however this experiment was not designed to test for antigen competition therefore further 
work would be needed into this matter in the future.  
In the paper I QPCR results, LPH did appear to play a role in extending the immune 
response in salmon injected with a high dose of flagellin+LPH even though no antibody 
response was detected. This was evident with Toll-like receptor 5 membrane-bound (TLR5M), 
interleukin-8 (IL-8), ) and TLR5 soluble (TLR5S) significant up-regulation 
of gene expression on 14DPI compared with the flagellin only injection and with 7DPI gene 
responses seen. The reason for the extended response is uncertain but could be due to the high 
concentration of flagellin effectively stimulating the innate immune system, causing the 
recruitment and further stimulation with LPH of immune-responsive cells. In the paper II 
QCR results, there were no significant mRNA gene expression differences between salmon 
injected with FlaD or FlaD+OVA for many of the genes that were reproducibly up-regulated 
(TLR5S, IL-8, interleukin-1 receptor (IL-1R), tumor necrosis factor receptor family super 
family 11B (TNFSF11B), hepcidin (HEP1), or matrix metalloproteinase 9 (MMP9) on 2DPI 
or 7DPI. There were also no reproducible differences in expression of a number of down-
regulated genes in microarray analysis such as lipopolysaccharide-induced tumor necrosis 
factor-alpha factor homolog (LITAF), myxovirus resistance 1 (Mx1), clusterin-1, 
transcription factor 21). There were many genes in common between FlaD and FlaD+OVA on 
2DPI (34), 7DPI (75) and for all groups and times (22) pointing to more of a time importance 
for gene expression rather than the inclusion of OVA. A number of genes that were up-
regulated only by one injection group at one time point (eg. 69 genes up-regulated in FlaD 
2DPI only) and these could provide clues as to the flagellin and OVA differences but they 
require further investigation. Flagellin appears to be the dominant factor producing the 
immune response in salmon with OVA not enhancing or negatively impacting the response. 
The inclusion of LPH as the model antigen resulted in the prolongment of the gene expression 




4.3 Innate Immune response 
4.3.1 In vitro response 
Cell culture trials were implemented to examine if the recombinant flagellin proteins 
bind to TLR5M, activating the NF- B response in a COS-7 cell line (from green monkeys) as 
measured by luciferase assay. FDS and FDL proteins were tested at increasing concentrations 
in this in vitro cell culture assay with or without the human anti-TLR5 antibody (pAb 
huTLR5). This antibody blocks the membrane-bound form of TLR5 found in mammals and 
therefore should reduce the NF- B response as flagellin is known to bind to TLR5 causing the 
downstream activation of the NF- B response in the innate immune system [28, 78, 166].  
The relative luciferase assay (RLA) seen in the in vitro cell culture experiments showed that 
FDS was less effective at stimulating the NF- B response as FDL. This indicated that the N-
(1-44) and C-(337-377) terminal residues may play some role in the binding of flagellin to 
TLR5. In the presence of a high concentration of FDL the addition of pAb huTLR5 caused the 
reduction of NF- B response which suggests that most of the activation occurred via TLR5. 
The same result did not occur in FDS stimulated cells which showed a much lower NF- B 
response and a lack of reduction of NF- B response after pAb huTLR5 addition. FDL appears 
to activate the TLR5 pathway more effectively than FDS in this assay. The response of the 
cells blocked with pAb huTLR5 was never completely suppressed, which indicated that there 
could be another pathway activated to initiate the NF- B pathway. Another possibility is that 
huTLR5 antibodies did not possess affinity enough against monkey COS-7 TLR5M to 
abrogate the TLR5M binding completely. Based on these results, we were interested in 
comparing the salmon’s response to FDL and FDS injection in vivo as was done in paper I.  
4.3.2 In vivo response 
TLR5 
Teleost fish are unique in having two forms of TLR5, soluble (TLR5S) and membrane 
bound (TLR5M). This unique feature could prove to be an important part of the innate 
immune response in fish. The response that we expected to see when flagellin is injected in 
Atlantic salmon is based on flagellin binding to TLR5. TLR5’s role in binding to flagellin 
initiates the myeloid differentiation primary response gene (MyD88)-dependent signaling 
cascade and culminates with the production of inflammatory cytokines and chemokines [28, 
78, 85, 167].  In paper I QPCR results, TLR5M was significantly up-regulated 7DPI in the 




whereas TLR5S was up-regulated in all groups 4DPI and only in the high dose flagellin+LPH 
groups 7DPI. The significance of the high down-regulation 14DPI is not known, but could 
prove to be important in the overall reduction of the innate immune response. In microarray 
results from paper II, TLR5M (represented as a feature on the 32K microarray) was not 
shown to reproducibly up-regulate. In a study with rainbow trout (Oncorhynchus mykiss) 
infected with Yersinia ruckeri (a facultative intracellular bacterium [168]), expression of 
TLR5M in the liver was low, ranging from 1.0-2.8 fold change and was never significantly 
different from the phosphate buffered saline (PBS) injected controls. However, there was 
significant up-regulation of a number of important inflammatory cytokines (IL-1 , IL-6, 
TNF , etc) which are known to be stimulated downstream of the NF- B pathway [169] and 
were also seen in the paper I results. Paper II QPCR results showed that TLR5S mRNA gene 
expression was significantly up-regulated on 2DPI and 7DPI in the spleens of FlaD and 
FlaD+OVA injected fish. Tsukada et al. [86] speculated that the stimulation of TLR5M by 
flagellin causes the induction of TLR5S expression in liver which can then bind to circulating 
flagellin and transport it back to TLR5M in the liver amplifying the danger signal in a positive 
feedback loop [86]. It would be interesting to follow flagellin after injection to see which 
organs flagellin enters and measure both forms of TLR5 in a time dependent manner to get a 
better understanding of which form is functioning and to see if a positive feedback loop 
functions in salmon.  
Ras/MAPK pathway 
 In mammalian species flagellin has been shown to stimulate the Ras/MAPK signaling 
pathways. The Ras genes family is involved in intracellular signaling networks and respond to 
diverse extracellular stimuli [170]. They represent an upstream signaling pathway that occur 
prior to the expression of the various inflammatory and apoptotic cytokines and chemokines 
of the immune system [170]. It can be difficult to measure the intermediate steps from 
receptor recognition of flagellin to cytokine production using QPCR or microarray analysis as 
there are often small fold changes in the various kinases and Ras genes throughout the 
signaling pathways that are constantly changing forms or being phosphorylated and de-
phosphorylated in a regulatory fashion [171, 172]. In paper II, two Ras genes up-regulated 
2DPI in FlaD+OVA injected salmon (Ras protein activator like 2 and Ras-related protein 
Rab-35) followed by a number of important inflammatory cytokines and chemokines. Purified 
flagellin activated the MAPK, stress-activated protein kinase and IKK signaling pathways 




are more focused research into the interplay between the TLR and MAPK signaling pathways 
[173] and this is an interesting area that has begun in fish research [174-176].  
Inflammation 
Stimulation of TLR5M and TLR5S with flagellin, initiates signaling pathways (TLR 
and Ras/MAPK pathways) which culminate in the expression of inflammatory cytokines that 
elicit various proinflammatory and chemotactic effects to aid in shaping both the innate and 
adaptive immune response. A number of important inflammatory cytokines, chemokines and 
receptors were significantly up-regulated in both studies in salmon injected with recombinant 
flagellin. In paper II, microarray results (confirmed by QPCR) for FlaD and FlaD+OVA 
injected salmon showed significant mRNA gene expression up-regulation of TNFRSF11B. 
TNFRSF11B is a member of the superfamily of TNF receptors which are important in a 
number of cellular signaling pathways involving inflammation, apoptosis, lymphocyte 
homeostasis and tissue development (Wiens and Glenney, in press [177]). In mammals, TNF 
ligands are known to bind to more than one receptor (Wiens and Glenney, in press [177]. 
Although TNFRSF11B has not been shown to bind to TNF , it seems to be important in the 
immune response of fish and in paper I, expression of TNF  was very high on 2DPI and 4DPI 
for all injection groups tested that included flagellin. TNF  is an important macrophage-
activation factor (MAF) produced by leukocytes and has been shown to induce a typical 
activated macrophage response evidenced by increases in respiratory burst activity, 
phagocytosis and nitric oxide production in rainbow trout [178], turbot [179], seabream [180, 
181] and catfish [182].  
TNF  and IL-8 are important T helper (TH) cytokines which can induce the production 
of acute-phase proteins or chemokines, incite feverish reactions and up-regulate expression of 
adhesion molecules on postcapillary venules, thereby triggering the recruitment of 
inflammatory cells, including neutrophils and monocytes, into cells [79]. IL-8 produces 
biological effects on neutrophils including: increased cytosolic calcium levels and respiratory 
burst, a change in neutrophil shape and chemotaxis [24]. In paper II, IL-8 reproducibly up-
regulated 2DPI in response to FlaD injection (microarray and QPCR results). In paper I, IL-8 
and IL-1  were weakly up-regulated in response to low dosage flagellin, but it appears that a 
high flagellin dose and antigen inclusion is necessary for elevated responses as was seen for 
IL-8 7DPI and IL-1  4DPI. IL-1  is well documented for its function in mediating responses 
to microbial invasion, inflammation, immunological reactions and tissue injury [183] and in 




significant up-regulation of the IL-1R in the FlaD and FlaD+OVA groups 2DPI (QPCR and 
microarray) and significant but lower up-regulation 7DPI (QPCR only). This receptor is a 
homologue of the mammalian type II IL-1R, which is mainly expressed in neutrophils, B cells 
and monocytes in comparison to the type I receptor which mainly expresses on T cells and 
fibroblast [185]. In mammals, the IL-1R type I mediates all known biological responses to IL-
1 whereas IL-1R type II is unable to deliver biological signals due to a lack of a signal 
transducing cytosolic domain and therefore it acts as a molecular trap for IL-1, negatively 
regulating IL-1 activity [185]. Due to the presence of a cytoplasmic tail in the salmonid IL-1R 
the function of this receptor may be different than in the mammalian homologue. However, 
IL-1R could be involved in the negative regulation of IL-
this possible role.  
In general, Atlantic salmon appear to be very sensitive to low concentrations of 
recombinant flagellin as was seen with few significant differences in gene expression between 
salmon treated with high and low doses of FDL and FDS (TLR5S, TNF , IL-1 , and IL-8). 
African green monkeys intramuscularly immunized with very low doses (1, 3, 10 or 30 µg) of 
an Oprf311-341-Oprl-A- and B-flagellin vaccine also showed a robust antigen-specific IgG 
response [112]. In order to prolong an immune response to flagellin, there appears to be a 
need for both a higher concentration of flagellin and the inclusion of an antigen (TLR5S, 
TLR5M, IL-6 and IL-8 up-regulation on day 7). There may be interplay that occurs among the 
innate immune response genes (IL-1 , , IL-8, etc) but further focus is needed on how 
they interact to gain a more thorough understanding of the immune system of salmon. 
Other innate immune genes 
It is thought that fish rely heavily on innate immune responses when defending against 
pathogens due to limited immunological memory [7, 23, 24, 34]. There were a number of 
immune genes not commonly known to respond to recombinant flagellin that reproducibly 
up-regulated in response to injection in salmon in paper II. There was up-regulation of 
antimicrobial peptides (AMP), which have broad antimicrobial activity against bacteria, fungi, 
parasites and viruses [16]. Cathelicidin and hepcidin exhibited highly up-regulated mRNA 
expression in microarray analysis, with hepcidin results confirmed by QPCR analysis. 
Hepcidin appeared to be an early immune gene, only significantly up-regulating 2DPI 
whereas cathelicidin maintained gene expression on 2DPI and 7DPI. Hepcidin is a regulator 
of iron homeostasis controlling iron absorption and macrophage iron release and also can 




multifunctional role in antibacterial defenses, angiogenesis, chemotaxis and recruiting cells to 
the adaptive immunity to the site of infection [187]. Cathelicidins are expressed in immune 
related tissues (kidney and spleen) or in tissue with direct contact with the environment (gills 
and skin) in Salmo trutta fario [19] and similarly in rainbow trout (gills, head kidney, and 
spleen for rainbow trout cathelicidin 1 [20]), which suggest involvement of these peptides in 
the innate immune system of salmonids.  
The complement system is important in innate immunity with roles in chemotaxis, 
opsonisation and destruction of invading pathogens [188]. Activation of this system can even 
enhance B-cell proliferation which links the innate and adaptive immune systems. In teleost 
fish, the complement system is well developed and includes many active subtypes, which may 
point to a more complex role in fish than in mammals [188]. In paper II, a number of 
complement genes were up-regulated including, complement component C7-1, C7 and 
complement factor D precursor. Complement component C7 is a single-chain glycoprotein 
that is involved in the cytolytic phase of complement activation through a sequence of 
polymerization reactions with other terminal components [189]. C7-1 from trout and C7 from 
flounder are highly similar and are known to play a crucial role in the hydrophilic-amphiphilic 
transition of the membrane attack complex thereby playing an essential role in the elimination 
of invading pathogens [189]. Complement factor D precursor is a member of the 
chymotrypsin family of serine proteases and plays an essential role in host-defense as the rate-
limiting enzyme in the alternative pathway of complement activation [190]. The combination 
of complement genes up-regulated in paper II, point to a role of the complement system in 
responding to the PAMP flagellin.  
C-type lectin receptor B was found to be up-regulated 2DPI in FlaD and FlaD+OVA 
groups and the 7DPI in FlaD+OVA group in microarray analysis. The family of C-type 
lectins and receptors are known to be important in innate immunity with roles in pathogen 
recognition and immune response [191]. They contain putative binding sites for the 
CCAAT/enhancer binding protein (C/EBP) transcription factors in their regulatory regions 
which may mediate their response to bacteria and LPS in salmon [191]. Interestingly, multiple 
C/EBP genes up-regulated in response to FlaD and FlaD+OVA 2DPI and 7DPI which may 
provide evidence of the linkage between these genes in the salmon’s response to flagellin. 
C/EBP transcription factors play vital roles in many cellular processes, including 
differentiation, energy metabolism and inflammation [192]. In human cell culture experiments, 
C/EBP was shown to activate the promoter driving transcription of the TNF receptor 1 




and 7DPI in both groups TNFRSF11B was up-regulated and while its role is not known in 
relation to C-type lectin or C/EBP, the possibility that all three genes work together in a 
flagellin stimulated immune response in salmon could be interesting for future studies. 
Role of down-regulation  
 When studying the immune response it is important to not only monitor the expression 
of up-regulated genes, but also to pay attention to the role that down-regulated genes play in 
the response. Down-regulated genes expression can be paramount in understanding the 
overall immune response, from initiation to a return to recovery state. In paper I, important 
cytokines -6, IL- -8) known to be produced downstream of the TLR signaling 
were up-regulated in response to flagellin injection and then down-regulation occurred by 
7DPI or 14DPI. This shows the salmon’s ability to reduce the inflammatory response which 
can be stressful and require increased energy usage. Down-regulation of IL-12 occurred on 
most days for all formulations of flagellin and LPH which was unexpected because IL-12 is 
an inflammatory cytokine known to be expressed by the MyD88 dependent signaling and NF-
-12 is secreted by the TH1 cells along with IFN  to protect the host against 
viral infections and infections by intracellular pathogens [193]. It could be possible that 
because the salmon was responding to an extracellular bacterial protein, then the genes 
responsible for intracellular pathogens defense were down-regulated. This possibility was 
supported by results in paper II, whereby the myxovirus resistance 1 (Mx1) gene down-
regulated in FlaD and FlaD+OVA groups 7DPI. The family of Mx proteins are antiviral 
proteins with intrinsic GTPase activity and function in endocytosis, intracellular vesicle 
transport and mitochondrial distribution (reviewed in [194]).  
4.4 Future prospects for vaccine design in fish  
4.4.1 Systems vaccinology 
The production of new fish vaccines in aquaculture have predominantly been based on 
relatively rudimentary methods. The majority of vaccines in use were developed empirically 
whereby inactivated pathogens were injected into fish and the survival measured [1]. This has 
produced some highly effective vaccines against bacterial diseases but variable results are 
seen for viral diseases and there are no successful vaccines against parasite infection. For 
salmonids, the majority of vaccines on the market are injectable multivalent oil-emulsions 
which are known to produce a number of serious side effects such as granulomas and intra-




methodologies for further understanding the immune response and for selecting more strategic 
components for vaccine components.  
In mammalian research, systems vaccinology is a new approach in vaccine 
development that encompasses a high-throughput multi-systems approach for biological 
measurement to determine molecular signatures that correlate with protective immune 
responses [195, 196]. A study in humans vaccinated with the well-established and effective 
yellow fever vaccine YF-17D followed the immune response up to one year to determine 
predicative gene signatures [131]. Using such high-throughput technologies as gene 
expression profiling (microarray and QPCR), assay for neutralizing antibodies, multiplex 
analysis of cytokines and chemokines, and multi-parameter flow cytometry, combined with 
computational modeling, Querec et al. [131] were able to determine multiple gene signatures. 
For example, the expression of the B cell growth factor tumor necrosis factor receptor 
superfamily, member 17 (TNFRSF17) predicted the neutralizing antibody response with up to 
100% accuracy. This model study demonstrated that “vaccine-induced innate immune 
responses can be used to predict the magnitude of the subsequent adaptive immune response 
and uncover new correlates of vaccine efficacy” [131]. Systems vaccinology can also be used 
for identifying vaccine responders versus non-responders, identifying new correlates of 
protection or mechanisms of vaccine action and predicting vaccine-induced adverse reaction 
[131, 195].  
While fish research is currently lacking some of the key tools needed for adapting the 
systems biology approach to vaccine design, there are still lessons that can be learned from 
this method. Mammalian research uses a combination of research methods from genomics, 
transcriptomics, proteomics, metabolomics and genetics with advanced computational 
methods [196]. With the advent of the more high-throughput techniques in fish research such 
as microarray and high-throughput DNA sequencing, the opportunity for adopting the systems 
vaccinology approach may be possible in future years. Vaccine development should focus on 
using a combination of methods for designing more efficacious vaccines, combining 




4.4.2 What next? 
 The production of a highly purified, soluble, recombinant flagellin protein provides an 
array of opportunities for future research studies. As these studies were the first to inject 
highly purified recombinant soluble flagellin into salmon, only the surface was scratched in 
terms of the roles flagellin plays in stimulating the immune response in salmon. Using the 
pAb FDS in immunohistochemistry studies could follow the organ distribution of flagellin 
after intraperitoneal injection in a time dependent manner, as well as investigating the location 
of flagellin intracellularly by electron microscopy.  
 Many of the bacterial diseases in salmon aquaculture have been controlled through the 
use of inactivated vaccines. Viral diseases continue to be a problem in the industry and may 
require a new, more sophisticated approach to vaccine design. The use of subunit vaccines 
may prove to be successful in controlling viral diseases. We have shown flagellin injection to 
stimulate important genes in the innate immune response of salmon and the next step would 
be to test the adjuvanticity of flagellin in a challenge trial with a viral disease. It would be 
interesting to mix the vaccine antigen and flagellin adjuvant with mineral oil, as mineral oil 
has been shown to produce a depot effect [197], an inflammatory response [146, 147] and 
could possibly prevent the degradation of protein subunits [198]. Due to the side-effects from 
mineral oil use in vaccines [55, 149, 199, 200], it would be interesting to also include a 
flagellin and antigen vaccine without mineral oil to compare the responses and efficacy as a 
vaccine. 
 Studies in mice [110, 111, 142, 201, 202]  and monkeys [112] have shown improved 
immunogenicity of vaccines when fusion proteins containing flagellin attached to an antigen 
are used and show potencies at lower dosages than when flagellin and antigen are used 
separately. One hypothesis proposed that the fusion protein allows flagellin to deliver the 
antigen in a form that facilitates antigen processing but does not contribute to the response via 
TLR5 signaling [84]. An appropriate antigen could be expressed with the flagellin adjuvant 







5. Main conclusions 
 Soluble form of highly purified recombinant flagellins from Vibrio anguillarum were 
produced in Escherichia coli BL21 (DE3) cells harboring pET151/D TOPO flagellin 
constructs in two lengths (full-length (FDL) and truncated (FDS)). 
 
 Both forms of flagellin (FDS and FDL) stimulate the immune system similarly but 
FDL expresses at lower amounts and with greater difficulty than FDS, as well as being 
less stable over time and at different storage temperatures therefore FDS is a stronger 
vaccine adjuvant candidate. 
 
 Recombinant FDL was shown to stimulate the NF-  more efficiently than 
the FDS in vitro in a luciferase assay. 
 
 Polyclonal flagellin antibody against FDS was produced in rabbit and shown to be 
functional in immunoblot analysis. 
 
 Innate immune response measured in Atlantic salmon after injection with recombinant 
flagellin as assessed by transcriptome analysis (QPCR and microarray). 
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